文献速递免疫规划妇幼与学校卫生

动机性访谈与儿童疫苗接受度:MOTIVE研究

Motivational interviewing and vaccine acceptance in children: The MOTIVE study.
PubMed 文献 · Vaccine · 2022-02-10

在美国一家联邦合格健康中心,对儿科和家庭执业提供者进行教育干预并实施基于动机性访谈的MOTIVE工具后,6个月至6岁儿童流感灭活疫苗覆盖率从32.4%升至43.9%(p<0.01),0-6岁儿童每100名患者记录的疫苗拒绝从31.5降至17.6(p<0.01)。

要点

  • MOTIVE工具与6个月至6岁儿童流感灭活疫苗覆盖率显著提高相关(32.4%对43.9%,p<0.01)。
  • MOTIVE工具与0-6岁儿童每100名患者疫苗拒绝记录减少相关(31.5对17.6,p<0.01)。
  • 0-18个月儿童Hib疫苗覆盖率显著提高,商业保险儿童DTaP、IPV和VAR疫苗覆盖率显著提高。

核心结论

  • 使用基于动机性访谈的沟通工具可能减少疫苗拒绝并提高儿童疫苗接种覆盖率,尤其是流感灭活疫苗。

研究设计与样本

  • 在美国一家联邦合格健康中心,儿科和家庭执业提供者完成关于疫苗犹豫和MOTIVE工具使用的教育干预,随后在0-6岁患者就诊时实施MOTIVE工具。
  • 数据收集自教育干预前1年(2018年7月至2019年6月,N=2504)和干预后(2019年7月至2020年3月,N=1954),以检查疫苗接种覆盖率和记录的疫苗拒绝的差异。

主要发现

  • MOTIVE工具的使用与6个月至6岁儿童流感灭活疫苗覆盖率显著增加相关(32.4%对43.9%,p<0.01)。
  • 0-18个月儿童Hib疫苗覆盖率显著增加。
  • 商业保险患者在干预期间DTaP、IPV和VAR疫苗覆盖率显著更高。
  • MOTIVE工具的使用与0-6岁儿童每100名患者记录的疫苗拒绝减少相关(31.5对17.6,p<0.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Vaccine coverage have been less than desired in young children in part due to parental vaccine hesitancy. Addressing health beliefs through patient-centered communication approaches such as motivational interviewing (MI) may improve vaccine confidence. Thus, the objective of this study was to determine the difference in paediatric vaccination coverage rates based on the Advisory Committee on Immunization Practices (ACIP) and Centers for Disease Control and Prevention (CDC) recommended schedule in children 0-6 years of age after an educational intervention for providers and integration of an MI-based communication tool, MOTIVE (MOtivational Interviewing Tool to Improve Vaccine AcceptancE). METHODS: Paediatric and family practice providers in a federally qualified health center in the United States completed an educational intervention regarding vaccine hesitancy and use of the MOTIVE tool. Providers then implemented the MOTIVE tool to address common health beliefs using strong, presumptive vaccine recommendations and an MI framework during encounters with patients 0-6 years of age. Data were collected from 1-year pre-educational intervention (July 2018-June 2019, N = 2504) and post-intervention (July 2019-March 2020, N = 1954) to examine differences in vaccination coverage rates and documented vaccine refusals. RESULTS: Use of the MOTIVE tool was associated with a statistically significant increase in IIV vaccination coverage rate in children 6 months to 6 years of age (32.4% versus 43.9%, p < 0.01). A significantly increased Hib vaccination coverage rate was observed in children 0-18 months of age. Patients with commercial insurance also had significantly higher vaccination coverage rates for the DTaP, IPV, and VAR vaccines during the intervention period. Use of the MOTIVE tool was associated with a decrease in documented vaccine refusals per 100 patients in children 0-6 years of age (31.5 versus 17.6, p < 0.01). CONCLUSION: Use of an MI-based communication tool may decrease vaccine refusals and improve childhood vaccination coverage rates, particularly for IIV. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT03934008, https://clinicaltrials.gov/ct2/show/NCT03934008, deidentified individual participant data will not be made available.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Cole JW, M H Chen A, McGuire K, et al. Motivational interviewing and vaccine acceptance in children: The MOTIVE study. Vaccine. 2022. PMID: 35153096. doi:10.1016/j.vaccine.2022.01.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。